Most social discussions acknowledge the publication's emphasis on personalized hormone therapy, with some posts highlighting its resistance to broad recommendations, as seen in phrases like 'no news is good news' and comments on the publication being essential for clinicians. The tone ranges from informative to slightly humorous, showing both respect and critical engagement with the topic, which demonstrates a moderate but meaningful influence on both professional and public conversations.
AgreementModerate agreement
Most discussions agree with the publication's focus on individualized treatment and the cautious stance on hormone therapy use for specific conditions.
InterestModerate interest
Participants show moderate interest, often referencing and sharing the publication's key points or analyses in discussions.
EngagementModerate engagement
Posts include direct quotations, references to guidelines, and sharing of external links, indicating active engagement.
ImpactModerate impact
The discussions reflect a recognition of the publication's importance in guiding clinical practice and public awareness about menopausal treatments.
Abstract in brief
The 2022 NAMS Hormone Therapy Position Statement updates previous guidelines by reviewing new research, involving an expert panel to assess evidence, and emphasizing personalized treatment plans to maximize benefits and minimize risks for women experiencing menopausal symptoms.
Hormone therapy is considered the most effective treatment for vasomotor symptoms and genitourinary issues related to menopause, as well as preventing bone loss, but its risks vary based on factors like type, dose, duration, and timing of use.
The benefits are generally favorable for women under 60 or within 10 years of menopause onset without contraindications, but risks such as heart disease and stroke increase for women starting therapy later or older than 60, leading to recommendations for careful, individualized treatment and periodic reevaluation.]
The 2022 Hormone Therapy Position Statement of The North American Menopause Society @MenopauseOrg is a must for any clinician who counsels peri or postmenopausal women regarding CV & all other aspects of Menopausal Hormone Therapy. https://t.co/LaTt3NYAvs https://t.co/bTqTzzImu3
Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpypZxz
#Menopause #WomensHealth #HRT #MHT
Nov 8, 2022 · 15 likes · 8 shares · 52,998 followersView post →
MJ
Menopause Journal
@MenopauseJrnl · X
NAMS Position Statement: The 2022 hormone therapy position statement of The North American Menopause Society https://t.co/dH43SvfyXL @MenopauseOrg @Lippincott #menopause #HormoneTherapy
Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz
#Menopause #WomensHealth #HRT #MHT https://t.co/Iq9z85gpVX
Oct 21, 2022 · 8 likes · 2 shares · 52,998 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
New—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz
#Menopause #WomensHealth #WorldMenopauseDay https://t.co/FdpIvWyadL
Oct 18, 2022 · 6 likes · 3 shares · 52,998 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
Rossella E Nappi comments on:
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyprI1
#Menopause #WomensHealth #HRT #MHT https://t.co/OuCRegxAVb
Oct 24, 2022 · 5 likes · 3 shares · 52,998 followersView post →
Estradiol directly affects skin quality by promoting collagen synthesis and skin thickness. Its decline during menopause leads to texture changes and reduced firmness, impacting aesthetic procedures and overall skin…
This video explores pre- and postmenopausal symptomology, diagnostic tools, and the latest medical guidelines for comprehensive gender-focused care during this reproductive stage.
Clear guidance on benefits, risks, and recent FDA label changes regarding hormone therapy for menopause symptoms, including safe use considerations and shared decision-making with clinicians.
Clinical follow-up of women on hormone therapy is essential for safety and effectiveness. This video explains necessary evaluations, symptom monitoring, laboratory studies, and therapeutic adjustments while emphasizing…
Question: Should hormone therapy be used for weight loss?
No. Hormone therapy has favorable effects on body composition but typically does not result in weight loss. See more in second image.
#hormonetherapy #weight #menopause
Question: I am in my 60s. Is it too late to start #hormonetherapy?
It depends. Shared decision-making between women and their clinicians is essential, because these discussions are often nuanced. See second image for more information.
References:
tinyurl.com/22v85s8f
tinyurl.com/ydwttjkv
Does #hormonetherapy prevent bone loss and protect against fracture risk?
Yes. HT is US-government approved for prevention of #boneloss and can be used for this purpose in appropriate candidates who do not have contraindications.
References: tinyurl.com/22v85s8f tinyurl.com/35kf8h8v
Question: Should hormone therapy be used to prevent dementia?
No. #Hormonetherapy is not recommended for prevention or treatment of cognitive decline or #dementia.
Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f. #menopause
Should hormone therapy be used to prevent #heartdisease?
No. #Hormonetherapy is not recommended for primary or secondary prevention of #cardiovasculardisease.
Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f
#menopause
@cazzachr @society_eas @nationallipid Well Caroline, that is asking a lot for a Tweet - Here is the best guidance. No longer called HRT but rather HT - https://t.co/IQA0uqOykc Have a laugh over my former NJ business card https://t.co/UztnfzIehR
May 2, 2023 · 1 like · 42,258 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
In the December Issue:
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz #Menopause #WomensHealth #MHT #HRT
Nov 23, 2022 · 2 likes · 52,998 followersView post →
TD
Thomas Dayspring
@Drlipid · X
@BrianDevorkin @ErinMichos @PeterAttiaMD Latest NAMS position statement on HT https://t.co/IQA0uqwWVC
Nov 9, 2022 · 1 like · 42,258 followersView post →
NS
Nancy Sánchez
@SgNans · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Nov 9, 2022 · 8 shares · 1,455 followersView post →
MJ
Mª José Jiménez.
@MJJEndocrino · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Nov 8, 2022 · 8 shares · 2,464 followersView post →
DJ
Dr. Shashank Joshi
@AskDrShashank · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Nov 8, 2022 · 8 shares · 32,592 followersView post →
DE
Dr. Hugo Corrales - Endocrinología.
@hugoendocrino · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Nov 8, 2022 · 8 shares · 6,478 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpypZxz
#Menopause #WomensHealth #HRT #MHT
Nov 8, 2022 · 15 likes · 8 shares · 52,998 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
Rossella E Nappi comments on:
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz
#Menopause #WomensHealth
Nov 2, 2022 · 2 likes · 52,998 followersView post →
K
Kaw
@kawtharelarbi · X
RT @TheLancetEndo: Rossella E Nappi comments on:
The 2022 hormone therapy position statement of The North American Menopause Society: no ne…
RT @TheLancetEndo: Rossella E Nappi comments on:
The 2022 hormone therapy position statement of The North American Menopause Society: no ne…
Oct 24, 2022 · 3 shares · 32,592 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
Rossella E Nappi comments on:
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyprI1
#Menopause #WomensHealth #HRT #MHT https://t.co/OuCRegxAVb
Oct 24, 2022 · 5 likes · 3 shares · 52,998 followersView post →
DJ
Dr. Shashank Joshi
@AskDrShashank · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Oct 21, 2022 · 2 shares · 32,592 followersView post →
DE
Dr. Hugo Corrales - Endocrinología.
@hugoendocrino · X
RT @TheLancetEndo: Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https:/…
Oct 21, 2022 · 2 shares · 6,478 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
Online—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz
#Menopause #WomensHealth #HRT #MHT https://t.co/Iq9z85gpVX
Oct 21, 2022 · 8 likes · 2 shares · 52,998 followersView post →
RR
Rosmeri Rivera
@RosmeriRivera9 · X
RT @TheLancetEndo: New—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.…
RT @TheLancetEndo: New—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.…
Oct 19, 2022 · 3 shares · 542 followersView post →
DJ
Dr. Shashank Joshi
@AskDrShashank · X
RT @TheLancetEndo: New—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.…
Oct 18, 2022 · 3 shares · 32,592 followersView post →
TE
The Lancet Diabetes & Endocrinology
@TheLancetEndo · X
New—The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news https://t.co/cMCHpyH2zz
#Menopause #WomensHealth #WorldMenopauseDay https://t.co/FdpIvWyadL
Oct 18, 2022 · 6 likes · 3 shares · 52,998 followersView post →
I
ISSWSH
@ISSWSH · X
The 2022 hormone therapy position statement of The North American Menopause Society is available to view: https://t.co/0pC1xSYIYx https://t.co/BmP9Ki9ios
The North American Menopause Society recently released its 2022 hormone therapy position statement.
AMS highlights and link to the statement are here. 1/3
https://t.co/KUhwSUiVUG
Aug 4, 2022 · 2 likes · 1 share · 1,535 followersView post →
ET
Endocrine Today
@EndocrineToday · X
RT @MenopauseJrnl: NAMS Position Statement: The 2022 hormone therapy position statement of The North American Menopause Society https://t.c…
"The 2022 Hormone Therapy Position Statement of The North American Menopause Society” has been published in the July 2022 issue of Menopause.
Read more, https://t.co/pfSdkocF8Y
NAMS last statement release was in 2017.
#menopause #womenshealth #nams #wholelifemedicine https://t.co/Ca9e1HzyYp
The 2022 hormone therapy position statement of The North American Menopause Society. Consenso terapia hormonal en la #menopausia https://t.co/UTj1DmiQW1
NAMS Position Statement: The 2022 hormone therapy position statement of The North American Menopause Society https://t.co/dH43SvfyXL @MenopauseOrg @Lippincott #menopause #HormoneTherapy
The 2022 Hormone Therapy Position Statement of The North American Menopause Society @MenopauseOrg is a must for any clinician who counsels peri or postmenopausal women regarding CV & all other aspects of Menopausal Hormone Therapy. https://t.co/LaTt3NYAvs https://t.co/bTqTzzImu3
Management of Menopausal Symptoms: A Review. ... The 2022 hormone therapy position statement of The North American Menopause Society. ... Position paper: ...
Articles. The 2022 hormone therapy position statement of The North American Menopause Society. Association between menopausal hormone therapy and risk of ...
FEBRASGO POSITION STATEMENT - Menopause in gynecologic ...
News
Source: Adapted from The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. ... “The 2022 Hormone Therapy Position ...
Updates in the Care of Women in Menopause - Lisa N. Kransdorf ...
News
The 2022 hormone therapy position statement of The North American Menopause society. Menopause, 2022; 29(7):767–794. Crossref · Google Scholar. 3. Holmberg L ...
Addressing Menopause Symptoms - Mayo Clinic Proceedings
News
The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022; 29:767-794. Google Scholar. 14. Constantine, G.D. ...
Update of the impact of menopausal hormone therapy on breast ...
News
The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022; 29:767-794. doi: 10.1097/GME.0000000000002028. PMID ...
العلاج الهرموني لانقطاع الطمث: هل يناسبك؟ - Mayo Clinic (مايو كلينك)
News
2022; doi:10.1097/GME.0000000000002028. The Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society ...
Salivary tests are available for a number of hormones. Salivary ...
News
... hormone-therapy.pdf. 7. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. (2022). Menopause: The Journal of the North ...
Management of Menopause Symptoms | Osteoporosis Canada
News
The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. Jul 1 2022;29(7):767-794. doi:10.1097/GME.0000000000002028.
[DOI: 10.1097/GME.0000000000002028] Otras fuentes: • North American Menopause Society (NAMS): www.menopause.org • International Menopause Society (IMS): www ...
La realidad del aumento de peso durante la menopausia - Mayo Clinic
News
2022; doi:10.1097/GME.0000000000002028. Productos y servicios. La Dieta de Mayo Clinic: ¿cuál es tu meta de pérdida de peso? See more In-depth. Ver también.
Long-term cognitive effects of menopausal hormone therapy ...
News
doi: 10.1097/GME.0000000000002028. pmid:35797481. 6. Dominus S. Women have been misled about menopause. N Y Times Mag. 2023 February 5, 2023. 7. Rossouw JE ...
The Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022; doi:10.1097/GME.0000000000002028.
Updates in Hormone Replacement Therapy for Survivors of ...
News
○ A recent review of HRT in patients with cervical cancers. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel ...
Terapia hormonal para la menopausia: ¿Es lo correcto para ti ...
News
2022; doi:10.1097/GME.0000000000002028. The Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society ...
doi: 10.1097/GME.0000000000002028 2. Stuenkel C.A. et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin ...
[PDF] The 2022 hormone therapy position statement of The North ...
News
The 2022 hormone therapy position statement of The North American Menopause Society · M. M. M. N. F. Carolyn J. Crandall, Dnp FNP-C Lori Davis, +10 authors
The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022;29:767-94. doi: 10.1097/GME.0000000000002028; Treatment ...
The 2023 nonhormone therapy position statement of The North ...
News
The 2022 Hormone Therapy Position Statement of The North American. Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The ...
Publications and Tools - Canadian Menopause Society
News
NAMS Position Statement: The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022;29(7):767-794. NAMS Position ...
Menopause hormone therapy: Is it right for you? - Mayo Clinic
News
2022; doi:10.1097/GME.0000000000002028. The Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society ...
Scopri i Benefici della BHRT nella Donna! La menopausa porta con ...
Facebook
doi: 10.1097/GME.0000000000002028 2. Stuenkel C.A. et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin ...
The 2022 hormone therapy position statement of The North ...
News
Abstract. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” (NAMS) updates. “The 2017 Hormone Therapy Position Statement ...
doi:10.1097/GME. 0b013e31824d8f40 The North American Menopause Society. Menopause. 2022. doi:10.1097/GME.0000000000002028 Crandall CJ et al. JAMA. 2023. doi ...
Nonhormonal Prescription Therapies for Moderate to Severe ...
News
doi:10.1097/GME.0000000000002028. 10. Biglia N, Bounous VE, De Seta F, Lello S, Nappi RE, Paoletti AM. Non-hormonal strategies for managing menopausal ...
Link: https://doi.org/10.1097/GME. 0000000000002028 • Rossouw et al., WHI, JAMA, 2002: Demonstrated significant improvements in BMD and reduced fractures across ...
Estrogen to treat Alzheimer's disease: Too little, too late? | Neurology
Blogs
https://doi.org/10.1097/GME.0000000000002028 · Crossref. Dena B. Dubal,; Phyllis M. Wise,. Estrogen and neuroprotection: from clinical observations to molecular ...
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” has been endorsed by more than 20 well-respected international ...
The 2022 hormone therapy position statement of The North ...
News
Abstract. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” (NAMS) updates. “The 2017 Hormone Therapy Position Statement ...
Update: Hormonal and Non-Hormonal Therapies in Menopause : r ...
Reddit
100mg progesterone mono therapy for my early peri-menopause ladies that are mostly complaining of sleep and irritability. Then add E2 as symptoms progress.
TD
TE
MJ
NS
MJ
RF
DG
AA
IM
DJ
DE
K
IJ
RR
I
AA
JC
KM
ET
SN
D
G
E
DC
L
DG
TP
JM
TS
TI
A
AM
DN
T
JS
JC
LP
BT
DN